<b><cite index="1-1">Tata Capital Healthcare Fund and Blue Earth Capital announced a $30 million investment in Tenet Diagnostics for an undisclosed equity stake</cite></b>

PE / VC 17 Aug 2026· $30 million · Completed· ◔ Reported

Tenet Diagnostics was founded in 2018 and has emerged as a leading integrated diagnostics platform focused on building a nationwide network of high-quality radiology and pathology centres, currently operating over 35 diagnostic centres across 14 states with a pan-India B2B laboratory network and over 3,000 superspecialty tests. The $30m raise is less a routine growth round and more an early bet on which platform will consolidate India's fragmented, $10bn-plus diagnostics market first, with funds going toward deepening Tenet's footprint across existing markets, strengthening its B2B network, and pursuing acquisitions. Tenet Medcorp Private Limited generated a revenue of ₹182Cr for the…

Why it mattersBlue Earth Capital is a limited partner in Tata Capital's healthcare fund rather than an independent co-investor, and the two firms have structured a round this way before, in a $9 million investment into Apex Kidney Care in early 2025-a structuring precedent for co-LP rounds through dedicated healthcare funds.
CounselDMD Advocates
SectorPharma & Healthcare
Value$30 million
[object Object][object Object][object Object][object Object][object Object][object Object][object Object][object Object][object Object]

Sources

Open in the live tracker →

Related deals